Iovance Biotherapeutics (IOVA) Leases (2019 - 2025)
Historic Leases for Iovance Biotherapeutics (IOVA) over the last 4 years, with Q3 2025 value amounting to $48.8 million.
- Iovance Biotherapeutics' Leases changed N/A to $48.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.8 million, marking a year-over-year change of. This contributed to the annual value of $55.2 million for FY2024, which is 1169.96% down from last year.
- Per Iovance Biotherapeutics' latest filing, its Leases stood at $48.8 million for Q3 2025.
- In the past 5 years, Iovance Biotherapeutics' Leases registered a high of $71.5 million during Q1 2024, and its lowest value of $48.8 million during Q3 2025.
- For the 3-year period, Iovance Biotherapeutics' Leases averaged around $60.4 million, with its median value being $62.5 million (2023).
- Per our database at Business Quant, Iovance Biotherapeutics' Leases soared by 154.05% in 2024 and then plummeted by 2882.29% in 2025.
- Quarter analysis of 3 years shows Iovance Biotherapeutics' Leases stood at $62.5 million in 2023, then decreased by 11.7% to $55.2 million in 2024, then fell by 11.66% to $48.8 million in 2025.
- Its Leases was $48.8 million in Q3 2025, compared to $49.9 million in Q2 2025 and $50.9 million in Q1 2025.